Taken together, our findings demonstrate that CCDC102B plays a crucial role in promoting early-stage breast cancer metastasis and could serve as a novel predictor of clinical outcomes in breast cancer patients and a potential therapeutic target for mitigating breast cancer metastasis. The gene discussed is CCDC102B; the disease is breast carcinoma.